Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:6617745rdf:typepubmed:Citationlld:pubmed
pubmed-article:6617745lifeskim:mentionsumls-concept:C0031809lld:lifeskim
pubmed-article:6617745lifeskim:mentionsumls-concept:C0205145lld:lifeskim
pubmed-article:6617745lifeskim:mentionsumls-concept:C0524637lld:lifeskim
pubmed-article:6617745lifeskim:mentionsumls-concept:C0282151lld:lifeskim
pubmed-article:6617745lifeskim:mentionsumls-concept:C0023688lld:lifeskim
pubmed-article:6617745lifeskim:mentionsumls-concept:C0243071lld:lifeskim
pubmed-article:6617745lifeskim:mentionsumls-concept:C0205099lld:lifeskim
pubmed-article:6617745lifeskim:mentionsumls-concept:C0068168lld:lifeskim
pubmed-article:6617745lifeskim:mentionsumls-concept:C0031959lld:lifeskim
pubmed-article:6617745pubmed:issue2-3lld:pubmed
pubmed-article:6617745pubmed:dateCreated1983-11-23lld:pubmed
pubmed-article:6617745pubmed:abstractTextNCA, the chloro analog of the potent dopamine agonist NPA is an irreversible ligand at dopamine receptors in mammalian brain. The chloroethyl analog of the recently described putative dopamine autoreceptor agonist 3-PPP, 3-PPP-C1, was evaluated for its potential use as an irreversible autoreceptor ligand. N-Chloroethylation of 3-PPP reduced the intrinsic affinity of the agonist seven-fold and, consequently, in contrast to NCA, it was found that 3-PPP-C1 was not a good irreversible ligand at dopamine receptors.lld:pubmed
pubmed-article:6617745pubmed:languageenglld:pubmed
pubmed-article:6617745pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6617745pubmed:citationSubsetIMlld:pubmed
pubmed-article:6617745pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6617745pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6617745pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6617745pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6617745pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6617745pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6617745pubmed:statusMEDLINElld:pubmed
pubmed-article:6617745pubmed:monthJullld:pubmed
pubmed-article:6617745pubmed:issn0014-2999lld:pubmed
pubmed-article:6617745pubmed:authorpubmed-author:WilliamsMMlld:pubmed
pubmed-article:6617745pubmed:authorpubmed-author:RobinsonJ LJLlld:pubmed
pubmed-article:6617745pubmed:authorpubmed-author:WatlingK JKJlld:pubmed
pubmed-article:6617745pubmed:issnTypePrintlld:pubmed
pubmed-article:6617745pubmed:day22lld:pubmed
pubmed-article:6617745pubmed:volume91lld:pubmed
pubmed-article:6617745pubmed:ownerNLMlld:pubmed
pubmed-article:6617745pubmed:authorsCompleteYlld:pubmed
pubmed-article:6617745pubmed:pagination235-8lld:pubmed
pubmed-article:6617745pubmed:dateRevised2006-11-15lld:pubmed
pubmed-article:6617745pubmed:meshHeadingpubmed-meshheading:6617745-...lld:pubmed
pubmed-article:6617745pubmed:meshHeadingpubmed-meshheading:6617745-...lld:pubmed
pubmed-article:6617745pubmed:meshHeadingpubmed-meshheading:6617745-...lld:pubmed
pubmed-article:6617745pubmed:meshHeadingpubmed-meshheading:6617745-...lld:pubmed
pubmed-article:6617745pubmed:meshHeadingpubmed-meshheading:6617745-...lld:pubmed
pubmed-article:6617745pubmed:meshHeadingpubmed-meshheading:6617745-...lld:pubmed
pubmed-article:6617745pubmed:meshHeadingpubmed-meshheading:6617745-...lld:pubmed
pubmed-article:6617745pubmed:year1983lld:pubmed
pubmed-article:6617745pubmed:articleTitleAssessment of the chloroethyl analog of 3-PPP (N-n-propyl-3-(3-hydroxyphenyl)-piperidine), 3-PPP-C1 as an irreversible ligand for central dopaminergic recognition sites.lld:pubmed
pubmed-article:6617745pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:6617745pubmed:publicationTypeIn Vitrolld:pubmed